Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, KY
Clinical Trial Details
Research Study Summary
Turning off the Alzheimer switch!
What is the purpose of this study?
The Sanders-Brown Center on Aging is currently working on a research study to examine the safety of a commonly-used, FDA-approved drug, Valproic acid, and test its potential to reduce Alzheimer-like changes in the brain of those with normal memory and thinking. This study has the potential to serve as a model for future drug development in Alzheimer's disease research.
Who can participate?
Anyone who is 65 and older and has normal memory and thinking abilities.
Why should I join?
- With your help, we can move one step closer to finding a cure for Alzheimer's disease.
- You will be kept up-to-date on the latest advances in aging and Alzheimer's disease research as well as gain access to clinical care with leading experts in the field.
What will happen if I join?
Participation involves seven visits to the Center over approximately 5 weeks and will include a supply of the study drug as well as experimental brain imaging, blood and spinal fluid collection as part of the study procedures.
For more information on this study and other clinical trials opportunities, please contact Sarah Tarrant at (859) 323-1331
To Learn more
Both Male and Female
Date Last Changed:
July 16, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these